ArticleNeuro-oncology2021

TERT promoter mutation: is it enough to call a WHO grade II astrocytoma IDH wild-type glioblastoma?

Caterina Giannini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.